Effects of pHA Hemoperfusion Plus Hemodialysis on Protein-Bound Uremic Toxins

NCT07016841 · clinicaltrials.gov ↗

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease on Dialysis

Interventions

DEVICE: pHA130 hemoperfusion device
DEVICE: HD/HDF
DEVICE: HA130 hemoperfusion device

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine